AAAAAA

   
Results: 1-7 |
Results: 7
Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors
Authors: Webber, SE Marakovits, JT Dragovich, PS Prins, TJ Zhou, R Fuhrman, SA Patick, AK Matthews, DA Lee, CA Srinivasan, B Moran, T Ford, CE Brothers, MA Harr, JEV Meador, JW Ferre, RA Worland, ST
Citation: Se. Webber et al., Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 11(20), 2001, pp. 2683-2686
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors
Authors: Dragovich, PS Zhou, R Webber, SE Prins, TJ Kwok, AK Okano, K Fuhrman, SA Zalman, LS Maldonado, FC Brown, EL Meador, JW Patick, AK Ford, CE Brothers, MA Binford, SL Matthews, DA Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors, BIOORG MED, 10(1), 2000, pp. 45-48
Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation
Authors: Reich, SH Johnson, T Wallace, MB Kephart, SE Fuhrman, SA Worland, ST Matthews, DA Hendrickson, TF Chan, F Meador, J Ferre, RA Brown, EL DeLisle, DM Patick, AK Binford, SL Ford, CE
Citation: Sh. Reich et al., Substituted benzamide inhibitors of human rhinovirus 3C protease: Structure-based design, synthesis, and biological evaluation, J MED CHEM, 43(9), 2000, pp. 1670-1683
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids
Authors: Dragovich, PS Webber, SE Prins, TJ Zhou, R Marakovits, JT Tikhe, JG Fuhrman, SA Patick, AK Matthews, DA Ford, CE Brown, EL Binford, SL Meador, JW Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids, BIOORG MED, 9(15), 1999, pp. 2189-2194
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
Authors: Matthews, DA Dragovich, PS Webber, SE Fuhrman, SA Patick, AK Zalman, LS Hendrickson, TF Love, RA Prins, TJ Marakovits, JT Zhou, R Tikhe, J Ford, CE Meador, JW Ferre, RA Brown, EL Binford, SL Brothers, MA DeLisle, DM Worland, ST
Citation: Da. Matthews et al., Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes, P NAS US, 96(20), 1999, pp. 11000-11007
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studiesof ketomethylene-containing peptidomimetics
Authors: Dragovich, PS Prins, TJ Zhou, R Fuhrman, SA Patick, AK Matthews, DA Ford, CE Meador, JW Ferre, RA Worland, ST
Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure - Activity studiesof ketomethylene-containing peptidomimetics, J MED CHEM, 42(7), 1999, pp. 1203-1212
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements
Authors: Dragovich, PS Prins, TJ Zhou, R Webber, SE Marakovits, JT Fuhrman, SA Patick, AK Matthews, DA Lee, CA Ford, CE Burke, BJ Rejto, PA Hendrickson, TF Tuntland, T Brown, EL Meador, JW Ferre, RA Harr, JEV Kosa, MB Worland, ST
Citation: Ps. Dragovich et al., Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P-1 lactam moieties as L-glutamine replacements, J MED CHEM, 42(7), 1999, pp. 1213-1224
Risultati: 1-7 |